Indication
trained immunity
2 clinical trials
1 product
2 drugs
Clinical trial
Continuous Atorvastatin Therapy Compared With Intermittent Atorvastatin Therapy for the Effect of LDL-c Level Variability and the Regulation of Trained ImmunityStatus: Recruiting, Estimated PCD: 2023-12-31
Drug
AtorvastatinClinical trial
BCG-induced Epigenetic Modifications in the NEXT GenerationStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Product
BCG-Vaccine SSIDrug
Varlilumab